Greatview Aseptic Packaging Crescita futura
Future criteri di controllo 2/6
Greatview Aseptic Packaging is forecast to grow earnings and revenue by 6.1% and 10.9% per annum respectively. EPS is expected to grow by 5.7% per annum. Return on equity is forecast to be 8.6% in 3 years.
Informazioni chiave
6.1%
Tasso di crescita degli utili
5.7%
Tasso di crescita dell'EPS
Packaging crescita degli utili | 31.0% |
Tasso di crescita dei ricavi | 10.9% |
Rendimento futuro del capitale proprio | 8.6% |
Copertura analitica | Low |
Ultimo aggiornamento | 12 Sep 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
We Think You Should Be Aware Of Some Concerning Factors In Greatview Aseptic Packaging's (HKG:468) Earnings
Apr 04Should You Investigate Greatview Aseptic Packaging Company Limited (HKG:468) At HK$1.73?
Dec 18Greatview Aseptic Packaging (HKG:468) Seems To Use Debt Rather Sparingly
Nov 02Is Now An Opportune Moment To Examine Greatview Aseptic Packaging Company Limited (HKG:468)?
Jun 19Calculating The Fair Value Of Greatview Aseptic Packaging Company Limited (HKG:468)
Apr 21Greatview Aseptic Packaging's (HKG:468) Returns On Capital Tell Us There Is Reason To Feel Uneasy
Jan 28Is It Time To Consider Buying Greatview Aseptic Packaging Company Limited (HKG:468)?
Jan 09Is Greatview Aseptic Packaging Company Limited (HKG:468) Trading At A 46% Discount?
Dec 06Is Greatview Aseptic Packaging (HKG:468) Using Too Much Debt?
Nov 17What Is Greatview Aseptic Packaging Company Limited's (HKG:468) Share Price Doing?
Sep 02Some Investors May Be Worried About Greatview Aseptic Packaging's (HKG:468) Returns On Capital
Aug 05Returns At Greatview Aseptic Packaging (HKG:468) Appear To Be Weighed Down
Mar 23Investors Met With Slowing Returns on Capital At Greatview Aseptic Packaging (HKG:468)
Nov 05Greatview Aseptic Packaging (HKG:468) Will Pay A Smaller Dividend Than Last Year
Sep 12Greatview Aseptic Packaging's (HKG:468) Dividend Is Being Reduced To HK$0.12
Aug 29Is Greatview Aseptic Packaging Company Limited (HKG:468) Potentially Undervalued?
Jun 30Returns At Greatview Aseptic Packaging (HKG:468) Appear To Be Weighed Down
Jun 10Is Greatview Aseptic Packaging Company Limited (HKG:468) Expensive For A Reason? A Look At Its Intrinsic Value
May 10Greatview Aseptic Packaging (HKG:468) Has A Rock Solid Balance Sheet
Mar 31Should You Investigate Greatview Aseptic Packaging Company Limited (HKG:468) At HK$4.23?
Mar 17We're Watching These Trends At Greatview Aseptic Packaging (HKG:468)
Feb 24Is Greatview Aseptic Packaging Company Limited's (HKG:468) 6.4% Dividend Sustainable?
Feb 09Greatview Aseptic Packaging (HKG:468) Share Prices Have Dropped 29% In The Last Three Years
Jan 25Is Greatview Aseptic Packaging Company Limited's (HKG:468) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Jan 10Greatview Aseptic Packaging Company Limited (HKG:468) Shares Could Be 49% Below Their Intrinsic Value Estimate
Dec 28Could The Greatview Aseptic Packaging Company Limited (HKG:468) Ownership Structure Tell Us Something Useful?
Dec 17How Should Investors Feel About Greatview Aseptic Packaging's (HKG:468) CEO Remuneration?
Dec 04We're Watching These Trends At Greatview Aseptic Packaging (HKG:468)
Nov 23Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
12/31/2026 | 4,628 | 297 | N/A | N/A | 1 |
12/31/2025 | 4,246 | 275 | N/A | N/A | 1 |
12/31/2024 | 3,730 | 254 | N/A | N/A | 1 |
6/30/2024 | 3,554 | 259 | 388 | 554 | N/A |
3/31/2024 | 3,686 | 252 | 363 | 498 | N/A |
12/31/2023 | 3,817 | 244 | 338 | 442 | N/A |
9/30/2023 | 3,935 | 230 | 215 | 309 | N/A |
6/30/2023 | 4,052 | 215 | 91 | 175 | N/A |
3/31/2023 | 3,995 | 199 | 174 | 260 | N/A |
12/31/2022 | 3,937 | 182 | 257 | 345 | N/A |
9/30/2022 | 3,813 | 195 | 259 | 329 | N/A |
6/30/2022 | 3,689 | 208 | 261 | 312 | N/A |
3/31/2022 | 3,577 | 246 | 153 | 223 | N/A |
12/31/2021 | 3,464 | 285 | 46 | 134 | N/A |
9/30/2021 | 3,348 | 308 | 166 | 264 | N/A |
6/30/2021 | 3,231 | 332 | 287 | 395 | N/A |
3/31/2021 | 3,135 | 337 | 364 | 457 | N/A |
12/31/2020 | 3,039 | 343 | 440 | 520 | N/A |
9/30/2020 | 2,960 | 332 | 445 | 409 | N/A |
6/30/2020 | 2,881 | 321 | 450 | 297 | N/A |
3/31/2020 | 2,794 | 329 | 388 | 326 | N/A |
12/31/2019 | 2,707 | 337 | 326 | 354 | N/A |
9/30/2019 | 2,582 | 347 | 199 | 337 | N/A |
6/30/2019 | 2,456 | 357 | 73 | 321 | N/A |
3/31/2019 | 2,474 | 358 | 174 | 356 | N/A |
12/31/2018 | 2,493 | 360 | 276 | 390 | N/A |
9/30/2018 | 2,493 | 358 | 252 | 376 | N/A |
6/30/2018 | 2,494 | 355 | 229 | 362 | N/A |
3/31/2018 | 2,415 | 349 | N/A | 333 | N/A |
12/31/2017 | 2,336 | 343 | N/A | 304 | N/A |
9/30/2017 | 2,264 | 341 | N/A | 371 | N/A |
6/30/2017 | 2,191 | 339 | N/A | 438 | N/A |
3/31/2017 | 2,180 | 336 | N/A | 548 | N/A |
12/31/2016 | 2,169 | 334 | N/A | 658 | N/A |
9/30/2016 | 2,209 | 329 | N/A | 715 | N/A |
6/30/2016 | 2,250 | 324 | N/A | 772 | N/A |
3/31/2016 | 2,234 | 320 | N/A | 574 | N/A |
12/31/2015 | 2,219 | 317 | N/A | 375 | N/A |
9/30/2015 | 2,139 | 295 | N/A | 274 | N/A |
6/30/2015 | 2,058 | 274 | N/A | 172 | N/A |
3/31/2015 | 2,145 | 277 | N/A | 270 | N/A |
12/31/2014 | 2,232 | 280 | N/A | 367 | N/A |
9/30/2014 | 2,295 | 306 | N/A | 299 | N/A |
6/30/2014 | 2,358 | 332 | N/A | 231 | N/A |
3/31/2014 | 2,259 | 324 | N/A | 232 | N/A |
12/31/2013 | 2,160 | 317 | N/A | 233 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: 468's forecast earnings growth (6.1% per year) is above the savings rate (2.3%).
Guadagni vs Mercato: 468's earnings (6.1% per year) are forecast to grow slower than the Hong Kong market (11.5% per year).
Guadagni ad alta crescita: 468's earnings are forecast to grow, but not significantly.
Ricavi vs Mercato: 468's revenue (10.9% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).
Ricavi ad alta crescita: 468's revenue (10.9% per year) is forecast to grow slower than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: 468's Return on Equity is forecast to be low in 3 years time (8.6%).